Brief: Strides Pharma Science Partners With Kenox To Expand Nasal Spray Portfolio
08/09/2025 14:51
Sept 8 (Reuters) - Strides Pharma Science Ltd SRID.NS: PARTNERS WITH KENOX TO EXPAND NASAL SPRAY PORTFOLIO TO EXPAND NASAL SPRAY PORTFOLIO FOR US MARKET Source text: ID:nBSE17p470 Further company coverage: SRID.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees